BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25951739)

  • 21. Genetic testing and interpretive complexity: a BRCA1 gene mutation example.
    Gogarty DS; Farrell MP; Gallagher DJ
    Ir J Med Sci; 2016 Nov; 185(4):955-957. PubMed ID: 25503966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common hereditary cancer syndromes.
    Greco KE; Mahon S
    Semin Oncol Nurs; 2004 Aug; 20(3):164-77. PubMed ID: 15491026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US panel rejects routine use of BRCA cancer screening in women.
    McCarthy M
    BMJ; 2013 Apr; 346():f2160. PubMed ID: 23558348
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
    Ballinger LL
    Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.
    Stuckey AR; Onstad MA
    Am J Obstet Gynecol; 2015 Aug; 213(2):161-5. PubMed ID: 25747548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program.
    Bunnell AE; Garby CA; Pearson EJ; Walker SA; Panos LE; Blum JL
    J Genet Couns; 2017 Feb; 26(1):105-112. PubMed ID: 27276934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
    Moreno L; Linossi C; Esteban I; Gadea N; Carrasco E; Bonache S; Gutiérrez-Enríquez S; Cruz C; Díez O; Balmaña J
    Clin Transl Oncol; 2016 Oct; 18(10):981-7. PubMed ID: 26742938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel.
    Moran O; Nikitina D; Royer R; Poll A; Metcalfe K; Narod SA; Akbari MR; Kotsopoulos J
    Breast Cancer Res Treat; 2017 Jan; 161(1):135-142. PubMed ID: 27798748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast Cancer: Genetics and Risk Assessment.
    Tejada-Bergés T
    Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counseling high-risk women about breast cancer.
    LeGrazie B
    Oncology (Williston Park); 2011 Feb; 25(2 Suppl Nurse Ed):30-5. PubMed ID: 25373281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic susceptibility for breast cancer: testing and primary prevention options.
    Baron RH; Borgen PI
    Oncol Nurs Forum; 1997 Apr; 24(3):461-8. PubMed ID: 9127359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
    Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
    Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
    [No Abstract]   [Full Text] [Related]  

  • 33. Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.
    Mahon SM
    Oncol Nurs Forum; 2013 May; 40(3):220-2. PubMed ID: 23615136
    [No Abstract]   [Full Text] [Related]  

  • 34. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing.
    Murphy CD; Lee JM; Drohan B; Euhus DM; Kopans DB; Gadd MA; Rafferty EA; Specht MC; Smith BL; Hughes KS
    Cancer; 2008 Dec; 113(11):3116-20. PubMed ID: 18932252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Recommendations for treatment of individuals at risk for hereditary breast and ovarian carcinoma].
    Radulović S; Branković-Magić M; Janković R; Ristanović M
    Srp Arh Celok Lek; 2003; 131(7-8):345-50. PubMed ID: 14692152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes and psychological impact of genetic testing, genetic counseling, and breast cancer risk assessment among women at increased risk.
    Hutson SP
    Oncol Nurs Forum; 2003; 30(2):241-6. PubMed ID: 12692658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know.
    Weitzel JN
    Surg Oncol Clin N Am; 2015 Oct; 24(4):705-32. PubMed ID: 26363538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
    Nelson HD; Pappas M; Zakher B; Mitchell JP; Okinaka-Hu L; Fu R
    Ann Intern Med; 2014 Feb; 160(4):255-66. PubMed ID: 24366442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients.
    Crawford B; Adams SB; Sittler T; van den Akker J; Chan S; Leitner O; Ryan L; Gil E; van 't Veer L
    Breast Cancer Res Treat; 2017 Jun; 163(2):383-390. PubMed ID: 28281021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.